Enliven Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AVTE
|
Aerovate Therapeutics, Inc. | $2.08 | $597.48 M | -6.84 | 51 | $0 |
 CELC
|
Celcuity Inc. | $14.40 | $501.59 M | -5.14 | 55 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $17.19 | $1.29 B | -7.16 | 85 | $0 |
 CMPX
|
Compass Therapeutics, Inc. | $1.88 | $180.24 M | -3.74 | 32 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $4.97 | $258.33 M | -17.08 | 9 | $0 |
 GOSS
|
Gossamer Bio, Inc. | $0.96 | $124.06 M | -0.65 | 135 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $41.72 | $2.47 B | -23.59 | 136 | $0 |
 IMRX
|
Immuneering Corporation | $2.66 | $40.63 M | -0.74 | 66 | $0 |
 INBX
|
Inhibrx Biosciences, Inc. | $15.55 | $241.02 M | -1.44 | 166 | $1.80 M |
 KRON
|
Kronos Bio, Inc. | $0.98 | $44.62 M | -0.37 | 58 | $6.29 M |
 LYRA
|
Lyra Therapeutics, Inc. | $0.26 | $19.53 M | -0.27 | 88 | $1.56 M |
 MACK
|
Merrimack Pharmaceuticals, Inc. | $15.15 | $223.75 M | -168.11 | 0 | $0 |
 MLTX
|
MoonLake Immunotherapeutics | $49.40 | $2.62 B | -57.88 | 50 | $0 |
 NVCT
|
Nuvectis Pharma, Inc. | $6.14 | $116.38 M | -4.5 | 13 | $0 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.49 | $85.40 M | -1.26 | 63 | $0 |
 REPL
|
Replimune Group, Inc. | $11.16 | $485.18 M | -2.44 | 331 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |